Steven Winoker -- UBS -- Analyst
Larry, if I think back to when Dave Cote took over Honeywell and Ed Breen took over Tyco in similarly difficult times and you've got Capital, the thing that's striking the most to me is at least these expanded investigations that came out today and the ongoing question about faith in the numbers that you've got to base your decisions on. So just trying to get a sense for what is giving -- where are you in kind of your continuum of getting confidence into the underlying numbers that are kind of at the core of basing the rest of the decisions on? And just before I go, if you can also just address Healthcare. You are saying it's very strong, just seemed a little flat in terms of the growth of 3%. Rest of the segment peers seem to be doing a little better, little confidence there too would be helpful. Thanks.
H. Lawrence Culp -- Chairman and Chief Executive Officer
Yeah. Steve, I would say, with respect to my discovery work here and beginning to kick things in a year, it's early. But what I'm focused primarily is, what we can change going forward in terms of the trajectory and the underlying performance. I think part of what we need to do at Power is wring out a little bit of the under-optimism that I think we referenced in our prepared remarks so that we can establish a baseline, that we can build on a baseline frankly for our own internal processes, let alone when we are talking about the business on the outside. In that regard, again it's early, but I have conviction that there are things to build upon, there are improvements that are well within our reach and we just need to -- we need to do that. And that again is not going to happen overnight. It's going to take some time, but I'm hopeful that we can build back credibility, deliver that performance over time.
Jamie Miller -- Chief Financial Officer, Senior Vice President
Steven, just a quick comment on Healthcare as you asked about. Healthcare revenues were up 3% on an organic basis. We saw segment profit up 10% on a consistent basis. And when you really peel back the layers, we're seeing very consistent growth across the different regions as well as in the product line. US was down a bit this quarter. We expected to have tough comps again in the fourth quarter, but largely driven to big orders we had last year from the VA in the US. China strength continues. And what the business is really doing well is getting really nice mix of growth in the market coupled with strong cost control and a real steady focus on how they're investing in R&D, so nice profile.
H. Lawrence Culp -- Chairman and Chief Executive Officer
And, Steve, just to be clear. I think we're well aware that Aviation really was the standout force in the third quarter of this year. My comments about the strength of the Healthcare business were not rooted in the last 90 days, but really looking at that business on a prospective basis. I think it's an outstanding business. They're well positioned in a number of attractive sub-markets and we intend to grow that going forward.
Operator
From Credit Suisse, we have John Walsh. Please go ahead.
John Walsh -- Credit Suisse -- Analyst
Hi, good morning.
Jamie Miller -- Chief Financial Officer, Senior Vice President
Good morning, John.
H. Lawrence Culp -- Chairman and Chief Executive Officer
Good morning, John.
John Walsh -- Credit Suisse -- Analyst
Hi. So I wanted to actually talk about Aviation because that was clearly a source of strength in the quarter and you reiterated your view of 15% plus on the OP line there. So that does imply sequentially that the margins are lighter. Obviously there's the LEAP ramp, or there's higher LEAP in Q4. But as we think about that longer term, because it will be a big driver of the future GE, do you still believe that the construct of holding the margins while you ramp LEAP is the right way to think about that business or has anything changed there?
Jamie Miller -- Chief Financial Officer, Senior Vice President
Yeah. I'll give a little bit of context on the quarter, the year, and just a macro level. In the quarter, we just continued to see real underlying strength in the business. Global passenger travel up 6.8% year-to-date. Passenger load factors at all time high which just means our engines are just flying more, which means we bill more hours under services contracts. We consume more parts as they go in for maintenance. We are seeing negative mix of the LEAP volume ramp. This has been partially offset by nice improvement in the product cost and at services, like I mentioned, just very strong spares rate and just strong spare part consumption at our T&M contracts. Peeling back and looking forward, we do see CFM coming down, but it's more than offset by military being stronger, the LEAP cost curve really coming down over the next few years and the services strength continuing. We expect to see continued healthy growth there, particularly as CFM continues to work its way through the services cycle. So backlog, strong revenue growth, air miles, strong services growth, and LEAP coming down the cost curve is probably the way to think about it.
John Walsh -- Credit Suisse -- Analyst
Thank you.
Operator
From Goldman Sachs, we have Joe Ritchie. Please go ahead.
Joe Ritchie -- Goldman Sachs -- Analyst
Thanks. Good morning, everyone.
H. Lawrence Culp -- Chairman and Chief Executive Officer
Good morning, Joe.
Jamie Miller -- Chief Financial Officer, Senior Vice President
Hi, Joe.
Joe Ritchie -- Goldman Sachs -- Analyst
So just a couple of quick clarifications. Jamie, on the net leverage target, I didn't see you guys explicitly call out 2020, but you did mention in the next few years, has that 2.5 times changed at all from a timing perspective? And then the second question, in just thinking about the comments around GE needing to support capital beyond the $3 billion in capital infusion in 2019, is the new insurance policy going to make you revisit the $15 billion capital outlay over the next few years?
Jamie Miller -- Chief Financial Officer, Senior Vice President
So, with respect to the first question on the net debt to EBITDA, we intend to reach net debt to EBITDA of 2.5 times. We plan to achieve that over time with substantial progress through 2020. That's really how we're thinking about that right now. With respect to the -- and I assume you're talking about the insurance accounting standard. That is something that, as I said, we expect will have a material impact on the financial statements not effective until 2021. It requires more granularity around loss testing. It changes the discount rate assumption and we will evaluate that over the next couple of years, but it does not impact the statutory reserve accounting and that is really what drives the capital funding requirements for insurance.